Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine

Objective Assess whether patients with chronic pain receiving 80 to 220 mg oral morphine sulfate equivalent of a full μ-opioid agonist could be transitioned to buccal buprenorphine at approximately 50% of their full dose without inducing opioid withdrawal or sacrificing analgesic efficacy. Methods. ...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pain Med
Hlavní autoři: Webster, Lynn, Gruener, Daniel, Kirby, Todd, Xiang, Qinfang, Tzanis, Evan, Finn, Andrew
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2016
Témata:
OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984426/
https://ncbi.nlm.nih.gov/pubmed/26917621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pm/pnv110
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky